Company profile

NanoVation company profile

NanoVation provides monitoring solutions for patients with chronic respiratory diseases. NanoVation detects respiratory changes before reaching critical stages. Their aim is to improve the outcomes of patient's respiratory deteriorations by enabling early identification and intervention at home. Their patented technology can identify subtle changes in patient's respiratory condition, enabling healthcare professionals to take proactive measures and prevent patient’s exacerbations and unnecessary hospitalizations. NanoVation was founded by Gregory Shuster.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2014-01-01

Headquarters

Headquarters
Kinvarra, Connacht, Ireland
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$5.9M
Last funding
Series Unknown / $5.9M / 2021-07-05
Last equity funding
Series Unknown / $5.9M
Investors
2
Lead investors
2
Founders
3

Founders and investors

Founders

Gregory ShusterHossam HaickNadav Bachar

Lead investors

European Innovation CouncilHorizon 2020

Investors

European Innovation CouncilHorizon 2020

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.